Online citations, reference lists, and bibliographies.
← Back to Search

Solid Lipid Nanoparticles: Production, Characterization And Applications.

W. Mehnert, K. Mäder
Published 2001 · Chemistry, Medicine
Referenced 1 time by Citationsy Users

Cite This
Download PDF
Analyze on Scholarcy
Share
Solid lipid nanoparticles (SLN) have attracted increasing attention during recent years. This paper presents an overview about the selection of the ingredients, different ways of SLN production and SLN applications. Aspects of SLN stability and possibilities of SLN stabilization by lyophilization and spray drying are discussed. Special attention is paid to the relation between drug incorporation and the complexity of SLN dispersions, which includes the presence of alternative colloidal structures (liposomes, micelles, drug nanosuspensions, mixed micelles, liquid crystals) and the physical state of the lipid (supercooled melts, different lipid modifications). Appropriate analytical methods are needed for the characterization of SLN. The use of several analytical techniques is a necessity. Alternative structures and dynamic phenomena on the molecular level have to be considered. Aspects of SLN administration and the in vivo fate of the carrier are discussed.
This paper references
Drug-loaded nanoparticles – preparation methods and drug targeting issues
E. Alleman (1993)
10.1021/JP9912612
Observation of Size-Dependent Melting in Lipid Nanoparticles
T. Unruh (1999)
Stabilization of dry liposomes by carbohydrates.
L. Crowe (1992)
10.1177/0148607181005003230
Invited Review: Development of Fat Emulsions
A. Wretlind (1981)
10.1016/0005-2736(85)90069-0
Protection of large unilamellar vesicles by trehalose during dehydration: retention of vesicle contents.
T. Madden (1985)
10.1213/00000539-197705000-00020
Thrombophlebitis After Intravenous Diazepam—Can It Be Prevented?
C. Graham (1977)
10.1016/0005-2736(91)90337-8
Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles.
J. Senior (1991)
10.1016/S0378-5173(98)00236-1
Solid lipid nanoparticles as drug carriers: II. Plasma stability and biodistribution of solid lipid nanoparticles containing the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate in mice
H. Heiati (1998)
10.1007/978-1-4684-7908-9_7
Stabilization of small, unilamellar phospholipid vesicles by sucrose during freezing and dehydration.
H. Hauser (1988)
非経口的栄養剤のための脂肪性エマルジョン III 低電解質負荷非経口的栄養剤のためのリポフンジンMCT/LCT法について
H. MuellerR (1994)
10.1016/0378-5173(94)00339-7
Preparation and evaluation in vitro of colloidal lipospheres containing pilocarpine as ion pair
R. Cavalli (1995)
Solid lipid nanoparticles (SLN) : an alternative colloidal carrier system for controlled drug delivery
R. Mueller (1995)
10.1023/A:1016064930502
Albumin Nanospheres as Carriers for Passive Drug Targeting: An Optimized Manufacturing Technique
B. Müller (2004)
10.1016/0014-5793(77)80633-9
The polar interactions between pancreatic lipase, colipase and the triglyceride substrate
B. Borgström (1977)
10.1016/0378-5173(90)90074-E
The secondary drying stage of freeze drying: drying kinetics as a function of temperature and chamber pressure☆
M. J. Pikal (1990)
Albumin adsorption on stealth and non-stealth solid lipid nanoparticles
R. Cavalli (1999)
Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting.
F. Martín (1982)
Behaviour of timolol incorporated in lipospheres in the presence of a series of phosphate esters
R. Cavalli (1992)
10.1016/0003-9861(85)90498-9
Preservation of freeze-dried liposomes by trehalose.
L. Crowe (1985)
The use of oil-in-water emulsions as a vehicle for parenteral drug administration.
R. Prankerd (1990)
10.1111/j.1365-2710.1976.tb00045.x
The emulsion–obsolete dosage form or novel drug delivery system and therapeutic agent?
S. Davis (1976)
10.1016/0378-5173(96)04539-5
Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles
R. Mueller (1996)
10.1016/0378-5173(94)90466-9
Incorporation in lipospheres of [d-Trp-6]LHRH
S. Morel (1994)
10.1016/0169-409X(90)90016-L
Parenteral emulsions for drug delivery
L. Collins-Gold (1990)
10.1016/S0378-5173(99)00431-7
Influence of spin probe structure on its distribution in SLN dispersions.
P. Ahlin (2000)
Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.
S. Huang (1992)
10.1023/A:1018962217258
High Resolution Size Determination of 20 nm Colloidal Gold Particles by SedFFF
Stephan Anger (2004)
10.1016/S0939-6411(98)00074-5
Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase.
C. Freitas (1999)
10.1016/0378-5173(86)90081-5
Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration
A. Smith (1986)
10.1016/S0378-5173(96)04822-3
Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles
R. Cavalli (1997)
10.1016/S0378-5173(97)00311-6
Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique
R. Mueller (1998)
10.1007/s002800050588
Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors
E. P. Sipos (1997)
10.1111/j.2042-7158.1986.tb03104.x
Pharmacological evaluation of an injectable prolonged release emulsion of physostigmine in rabbits
S. Benita (1986)
10.1016/0169-409X(95)00022-Y
Which polymers can make nanoparticulate drug carriers long-circulating?
V. Torchilin (1995)
10.1016/0168-3659(94)90253-4
Phase transition temperature reduction and glass formation in dehydroprotected lyophilized liposomes
W. Mobley (1994)
10.1016/0378-5173(95)00098-4
Long acting injectable oxytetracycline-liposphere formulations
A. Domb (1995)
10.1016/S0928-0987(99)00071-8
Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: mechanism of the protective effect.
M. Jumaa (2000)
Freeze-drying of emulsions--influence of congealing on granulometry research of a cryoprotective agent.
Y. Bensouda (1989)
Liposomes as targetable drug carriers.
V. Torchilin (1985)
10.2165/00003088-199223040-00004
Liposomal and Lipid Formulations of Amphotericin B
R. Janknegt (1992)
10.1016/0378-5173(95)04388-8
Thymopentin in solid lipid nanoparticles
S. Morel (1996)
10.1016/0378-5173(95)04286-5
Crystallization tendency and polymorphic transitions in triglyceride nanoparticles
H. Bunjes (1996)
10.1016/S0378-5173(99)00066-6
Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with β-cyclodextrins
R. Cavalli (1999)
10.3109/02652048409031539
Lyophilized liposomes: a new method for long-term vesicular storage.
P. Shulkin (1984)
Effects of some experimental factors on the production process of solid lipid nanoparticles
R. Cavalli (1996)
10.1016/S0378-5173(99)00428-7
Investigation on the viscoelastic properties of lipid based colloidal drug carriers.
A. Lippacher (2000)
10.1016/S0001-8686(98)00063-3
Structure, dynamics and transport properties of microemulsions
S. P. Moulik (1998)
The theory of high-pressure homogenization
S. Jahnke (2001)
Electron diffraction of solid lipid nanoparticles loaded with aciclovir
G. Lukowski (1997)
Characterization of macro molecules, colloids and particles by field-flow fractionation=Characterisierung von Makromolekülen, Kolloiden und Partikeln mit der Field-Flow Fractionation
Stephan Anger (2000)
10.1016/0005-2736(86)90411-6
Prevention of fusion and leakage in freeze-dried liposomes by carbohydrates
L. Crowe (1986)
10.1093/AJHP/31.2.149
Interactions between drugs and plastic intravenous fluid bags. II. Leaching of chemicals from bags containing various solvent media.
P. Moorhatch (1974)
10.1016/S0168-3659(99)00223-0
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties.
V. Jenning (2000)
Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions
B. Siekmann (1996)
Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions
P. Ahlin (1998)
10.1002/JPS.2600790307
Pharmacokinetics of two alternative dosage forms for cyclosporine: liposomes and intralipid.
S. Venkataram (1990)
10.1111/j.1749-6632.1987.tb45793.x
Lipid Emulsions as Drug Delivery Systems
S. Davis (1987)
10.1201/9781498710565
Colloidal Drug Delivery Systems
J. Kreuter (1994)
Controlled drug delivery with nanoparticles : current possibilities and future trends
P. Couvreur (1995)
10.1016/S0378-5173(96)04731-X
Biodegradation of solid lipid nanoparticles as a function of lipase incubation time
R. Mueller (1996)
10.1016/0024-3205(87)90138-X
The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908.
L. Illum (1987)
10.1006/PHRS.1999.0509
Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN).
G. Zara (1999)
10.1016/S0168-3659(99)00007-3
Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain.
S. Yang (1999)
10.3109/03639049109043831
Effect of sugars on freeze-thaw and lyophilization of liposomes
S. Vemuri (1991)
Drug release and release mechanism of prednisolone loaded Solid Lipid Nanoparticles
A. Z. Mühlen (1998)
10.1016/S0939-6411(97)00150-1
Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.
A. Zur Mühlen (1998)
10.1016/0165-6147(94)90314-X
Long-circulating (sterically stabilized) liposomes for targeted drug delivery.
T. Allen (1994)
10.3109/10611869609015973
Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.
R. Mueller (1996)
10.1016/0378-5173(94)90213-5
Fat emulsions for parenteral nutrition. III: Lipofundin MCT/LCT regimens for total parenteral nutrition (TPN) with low electrolyte load
R. H. Müller (1994)
10.1080/026520499288690
Solid lipid nanoparticles (SLN/Lipopearls)--a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products.
A. Dingler (1999)
10.1016/S0168-3659(97)00046-1
Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential
K. Westesen (1997)
10.1016/S0378-5173(98)00282-8
Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles
C. Bocca (1998)
10.1016/S0378-5173(98)00092-1
Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions
C. Freitas (1998)
10.3109/02652049809006847
Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization.
H. Heiati (1998)
10.1016/0005-2736(86)90303-2
The interaction of saccharides with lipid bilayer vesicles: stabilization during freeze-thawing and freeze-drying.
G. Strauss (1986)
Timolol in lipospheres.
M. Gasco (1992)
10.1016/0378-5173(86)90134-1
Physostigmine emulsion: a new injectable controlled release delivery system
S. Benita (1986)
10.3109/03639049509048106
Application of an Original process for Obtaining Colloidal Dispersions of Some Coating Polymers. Preparation, Characterization, Industrial Scale-Up
A. Labouret (1995)
SOLID LIPID NANOPARTICLES : PHAGOCYTIC UPTAKE, IN VITRO CYTOTOXICITY AND IN VITRO BIODEGRADATION : 1ST COMMUNICATION
R. H. Muller (1999)
10.1016/0022-1759(83)90303-4
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.
T. Mosmann (1983)
10.1016/S0939-6411(97)00107-0
NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes.
S. Morel (1998)
10.1016/S0939-6411(98)00023-X
Transformation of a liposomal dispersion containing ibuprofen lysinate and phospholipids into mixed micelles - physico-chemical characterization and influence on drug permeation through excised human stratum corneum.
I. Stoye (1998)
Ph
李幼升 (1989)
10.1016/0378-5173(94)00347-8
Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix
K. Westesen (1995)
10.1093/AJHP/49.11.2749
Fat emulsion particle-size distribution in total nutrient admixtures.
R. Mehta (1992)
10.1016/S0168-3659(97)01653-2
Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes
R. Mueller (1997)
Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
A. Gabizon (1994)
10.1016/S0378-5173(99)00424-X
Influence of different parameters on reconstitution of lyophilized SLN.
E. Zimmermann (2000)
10.1016/S0378-5173(99)00413-5
Solid lipid nanoparticles as drug carriers for topical glucocorticoids.
C. A. S. Maia (2000)
10.1016/S0939-6411(97)00172-0
Spray-drying of solid lipid nanoparticles (SLN TM).
C. Freitas (1998)
10.1016/0168-3659(90)90013-J
Nanocapsules as carriers for oral peptide delivery
C. Damgé (1990)
10.1016/0378-5173(93)90237-A
Positively charged submicron emulsions — a new type of colloidal drug carrier
E. Elbaz (1993)
10.1016/S0378-5173(99)00049-6
Nanospheres of cyclosporin A: poor oral absorption in dogs.
J. Ford (1999)
10.1016/S0378-5173(97)00222-6
Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN).
Schwarz (1997)
HPMA copolymer-bound anticancer drugs: Mechanism of action on cellular and subcellular levels
J. Kopeček (1999)
10.1016/0008-6215(94)00294-P
Imaging xanthan gum by atomic force microscopy
A. Kirby (1995)
10.1016/0378-5173(86)90236-X
Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules
N. A. K. Fallouh (1986)
10.1016/0378-5173(93)90313-5
Solid lipospheres of doxorubicin and idarubicin
R. Cavalli (1993)
10.1016/S0378-5173(97)04890-4
Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles
K. Westesen (1997)
10.1200/JCO.1986.4.5.789
Intravenous infusion of high doses of liposomes containing NSC 251635, a water-insoluble cytostatic agent. A pilot study with pharmacokinetic data.
J. Sculier (1986)
10.3109/02652049409051118
Autoclaving of liposomes.
A. Lukyanov (1994)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
The effect of the components of microemulsions on both size and crystalline structure of solid lipid nanoparticles (SLN) containing a series of model molecules
R. Cavalli (1998)
10.1016/0378-5173(89)90329-3
Design and characterization of a submicronized o/w emulsion of diazepam for parenteral use
M. Y. Levy (1989)
10.1016/S0378-5173(96)04782-5
Solid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate
H. Heiati (1997)
10.1016/S0378-5173(97)04885-0
Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters
A. J. Almeida (1997)
10.1126/SCIENCE.8128245
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
10.1016/0378-5173(93)90177-H
Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction
K. Westesen (1993)
Albumin microspheres for study of the reticuloendothelial system.
U. Scheffel (1972)
10.1007/978-1-4899-2905-1_8
Physical Properties — Structural and Physical Characteristics
K. Larsson (1986)
10.1136/adc.67.12.1475
Hazards of parenteral treatment: do particles count?
J. Puntis (1992)
10.1080/026520499289310
Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte.
C. Freitas (1999)
10.1016/S0378-5173(98)00404-9
Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures.
C. Olbrich (1999)
10.1126/SCIENCE.2928794
Imaging crystals, polymers, and processes in water with the atomic force microscope.
B. Drake (1989)
10.1016/0016-5085(80)90777-5
Importance of phospholipids, pancreatic phospholipase A2, and fatty acid for the digestion of dietary fat: in vitro experiments with the porcine enzymes.
B. Borgström (1980)
10.1016/0005-2736(94)90003-5
Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity.
V. Torchilin (1994)
Fate and behavior of liposomes in vivo: a review of controlling factors.
J. H. Senior (1987)
10.1016/0378-5173(93)90315-7
In vitro uptake of polystyrene latex particles and parenteral fat emulsions by human granulocytes
S. Rudt (1993)
Stabilization of liposomes by freeze-thaw- and lyophilization techniques : problems and opportunities
M. Ausborn (1992)
10.1016/0304-3991(92)90418-J
In situ investigations of single living cells infected by viruses.
W. Haeberle (1992)
10.1021/bp990135c
Gaulin Homogenization: A Mechanistic Study
R. Lander (2000)
10.1016/S0928-0987(97)86243-4
Solid lipid nanoparticles (SLN) for controlled drug delivery
R. Mueller (1996)
10.1248/CPB.31.237
Influence of fatty acid composition on the properties and polymorphic transition of fatty suppository bases.
H. Yoshino (1983)
10.1016/0378-5173(93)90015-8
A new in vitro technique for the evaluation of drug release profile from colloidal carriers - ultrafiltration technique at low pressure
B. Magenheim (1993)
10.1016/0304-4157(92)90038-C
Sterically stabilized liposomes.
M. Woodle (1992)



This paper is referenced by
10.4236/JCDSA.2016.61007
Silver Nanoparticles in Cosmetics
S. Gajbhiye (2016)
10.1002/adhm.201200338
Optically traceable solid lipid nanoparticles loaded with siRNA and paclitaxel for synergistic chemotherapy with in situ imaging.
K. H. Bae (2013)
10.1007/s13204-018-0758-0
Effect of two glycyrrhizinic acid nanoparticle carriers on MARC-145 cells actin filaments
Samantha Jardon (2018)
10.1016/j.ijpharm.2010.12.002
Performance evaluation of PAMAM dendrimer based simvastatin formulations.
Hitesh Kulhari (2011)
10.1007/S11483-008-9057-8
Effect of Cooling and Heating Rates on Polymorphic Transformations and Gelation of Tripalmitin Solid Lipid Nanoparticle (SLN) Suspensions
T. Awad (2008)
10.2174/1381612826666200206094529
LIPID-BASED NANOSYSTEM AS INTELLIGENT CARRIERS FOR VERSATILE DRUG DELIVERY APPLICATIONS.
Harshita (2020)
10.1517/17425255.4.1.65
In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability
D. Fatouros (2008)
10.2174/157340707783220301
Innovative Drug Delivery Systems for the Administration of Natural Compounds
D. Paolino (2007)
10.1016/j.ijpharm.2019.03.056
QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment
Gulin Amasya (2019)
10.1023/B:PHAM.0000019291.36636.c1
Structural Characterization of Q10-Loaded Solid Lipid Nanoparticles by NMR Spectroscopy
Sylvia A. Wissing (2004)
10.1691/PH.2009.8222
Solid lipid nanoparticle (SLN) formulations as a potential tool for the reduction of cytotoxicity of saponins.
H Van de Ven (2009)
10.1504/IJBET.2009.022913
Nanostructured Lipid Carriers and their application in drug delivery
Swamini Khurana (2009)
Preparation Methods of Solid Lipid Nanoparticles for Hydrophilic Peptides and Proteins
Xu Qun-wei (2010)
A Novel Approch For Development And Charectrization Of Etoposide Loaded Solid Lipid Nanoparticles
Sompur C.K.A (2011)
10.1016/J.POWTEC.2013.01.037
Preparation and characterization of quercetin-loaded solid lipid microparticles for pulmonary delivery
Luis Felipe Costa Silva (2013)
10.1016/j.foodchem.2013.05.120
Formation of solid shell nanoparticles with liquid ω-3 fatty acid core.
Hanna Salminen (2013)
10.3109/02652048.2013.788090
Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution
Ana Beloqui (2014)
10.1016/J.CEJ.2013.12.105
Multiple orifices in customized microsystem high-pressure emulsification: The impact of design and counter pressure on homogenization efficiency
J. H. Finke (2014)
10.1166/JBN.2014.1834
Effect of iontophoresis on topical delivery of doxorubicin-loaded solid lipid nanoparticles.
S. F. Taveira (2014)
10.2174/1567201811666140613112721
Development of etofenamate-loaded semisolid sln dispersions and evaluation of anti-inflammatory activity for topical application.
Ulya Badilli (2015)
10.1016/J.COLSURFA.2015.04.036
The controlled aggregation and tunable viscosity of nanostructured lipid carrier dispersions
Yihui Yang (2015)
10.1007/s11095-015-1780-5
Ceramide and N,N,N-Trimethylphytosphingosine-Iodide (TMP-I)-Based Lipid Nanoparticles for Cancer Therapy
Prabagar Balakrishnan (2015)
10.1007/s00706-016-1753-3
Kinetic and thermodynamic studies of methotrexate adsorption on chitosan-modified magnetic multi-walled carbon nanotubes
Bahman Vasheghani Farahani (2016)
10.1208/s12249-020-01711-2
Enhanced Oral Bioavailability of Felodipine from Solid Lipid Nanoparticles Prepared Through Effervescent Dispersion Technique
Yingmeng He (2020)
10.1002/MASY.201800011
Size and Vitamin E Release of Nanostructured Lipid Carriers with Different Liquid Lipids, Surfactants and Preparation Methods
Ingrid Dantas Luciano de Souza (2019)
10.2174/157341312800167542
Folate Targeted Solid Lipid Nanoparticles of Simvastatin for Enhanced Cytotoxic Effects of Doxorubicin in Chronic Myeloid Leukemia
Jaleh Varshosaz (2012)
Nanopartículas e suas aplicações em Ciências Farmacêuticas
N. Franco (2013)
10.1111/1750-3841.13642
Encapsulation of Beta-carotene in Lipid Microparticles Stabilized with Hydrolyzed Soy Protein Isolate: Production Parameters, Alpha-tocopherol Coencapsulation and Stability Under Stress Conditions.
Thais C. Brito-Oliveira (2017)
10.1590/0104-6632.20170343S20150669
Fatty acids profile of chia oil-loaded lipid microparticles
M. F. Souza (2017)
10.1016/j.ijpharm.2019.118487
The role of chitosan as coating for Nanostructured Lipid Carrier for skin delivery of fucoxanthin.
Leticia Malgarim Cordenonsi (2019)
10.2147/IJN.S133832
Physicochemical characterization of drug nanocarriers
Eloísa Berbel Manaia (2017)
10.5772/26878
LNCaP Prostate Cancer Growth In Vivo: Oncostatic Effects of Melatonin as Compared to Hypoxia and Reoxygenation
Laura Terraneo (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar